CN1602859A - Dripping pills of methoxsalen and its preparation method - Google Patents

Dripping pills of methoxsalen and its preparation method Download PDF

Info

Publication number
CN1602859A
CN1602859A CNA200410055335XA CN200410055335A CN1602859A CN 1602859 A CN1602859 A CN 1602859A CN A200410055335X A CNA200410055335X A CN A200410055335XA CN 200410055335 A CN200410055335 A CN 200410055335A CN 1602859 A CN1602859 A CN 1602859A
Authority
CN
China
Prior art keywords
methoxsalen
coolant
preparation
polyethylene glycol
dissolution
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CNA200410055335XA
Other languages
Chinese (zh)
Inventor
钱进
许军
彭红
李平
朱丹
刘孝乐
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Nanchang Hongyi Technology Co Ltd
Original Assignee
Nanchang Hongyi Technology Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nanchang Hongyi Technology Co Ltd filed Critical Nanchang Hongyi Technology Co Ltd
Priority to CNA200410055335XA priority Critical patent/CN1602859A/en
Publication of CN1602859A publication Critical patent/CN1602859A/en
Pending legal-status Critical Current

Links

Landscapes

  • Medicinal Preparation (AREA)

Abstract

The invention uses super micro shattering and drop pills producing the technology to produce fenfluramine drop pills, reaching the purposes such as increasing speed, and dissolution of disintegration, increasing the medicine stability, reducing the dose of auxiliary materials and decreasing cost, with rapid effect and convenient use. It can be buccal as well as deglutition, has remarkable conformity, and is especially suitable for children, older man, sicker in bed or with difficulty of swallowing.

Description

Methoxsalen drop pill and preparation method thereof
Technical field
The present invention relates to a kind of pharmaceutical product and preparation method thereof, specifically methoxsalen drop pill and preparation method thereof.
Background technology
Methoxsalen is a photosensitizer, can be activated by the long wave ultraviolet of wavelength at 320~400nm with the bonded 8-MOP of epidermis cell, and the maximum effect wavelength is 365nm.Under the effect of long wave ultraviolet, the thymus pyrimidine generation photochemical reaction on 8-MOP and the epidermal dna Double helix forms photoadduct, produce phototoxic reaction, synthetic and the mitoschisis of epidermal dna is suppressed, and the epidermis cell renewal speed is slowed down, thereby psoriasis is played therapeutical effect.The result of photosensitivity reaction also makes the tryrosinase vigor in the melanocyte increase, and impels melanocyte to form; Impel the melanocyte in the hair follicle in epidermis, to move, occur pigmentation on the skin thereby make.
Methoxsalen oral about 95% combines with plasma albumin from gastrointestinal absorption, with epidermis cell stronger adhesion is arranged.Photosensitization peaked in the back of taking medicine in 1.5~3 hours, and sustainable 8 hours, at liver metabolism, 95% metabolite was discharged from kidney in 24 hours.Methoxsalen needs to share (being called the PUVA therapy) with long wave ultraviolet (UVA), and treatment psoriasis, vitiligo, cutaneous T cell lymphoma also can be used for the treatment of palmoplantar pustulosis, eczema, atoipc dermatitis, lichen planus etc.
Methoxsalen is insoluble in water, and its disintegration of tablet time is long, and dissolution and dissolution rate are low, absorption difference, bioavailability is low, and the supplementary product consumption ratio is big, child, old people, bed patient and dysphagia patients are taken inconvenience, and compliance is poor, have influenced the performance of methoxsalen therapeutical effect.
The present invention makes the methoxsalen drop pill by using ultramicro communication technique and dropping pill formulation Technology exactly, thereby overcomes the above defective of methoxsalen sheet, and the therapeutical effect of methoxsalen is given full play to.
Summary of the invention
The methoxsalen drop pill of making by using ultramicro communication technique and dropping pill formulation Technology not only have disintegrate molten loose fast, dissolution and dissolution rate improve, steady quality, the pill volume is little, both can swallow also can buccal, easy to carry and use, onset is rapid, compliance is good, be particularly suitable for the characteristics that child, old people, bed patient and dysphagia patients are taken, but also have working condition and production equipment is simple, production cost is low, compare the advantage that supplementary product consumption reduces with tablet, demonstrated fully the new drug research exploitation spirit that people-oriented.
For achieving the above object, the present invention by the following technical solutions: the methoxsalen fine powder of 1 weight portion through micronizing is added in 1~10 weight portion molten matrix, abundant mixing, dropping preparation method is condensed into ball in coolant, remove coolant, drying, promptly.
The chemical name of methoxsalen is 9-methoxyl group-7-hydrogen-furan a pair of horses going side by side (3.2-g) (1) benzene a pair of horses going side by side pyrans-7-ketone among the present invention, and structural formula is
Figure A20041005533500041
Molecular formula is C 12H 8O 4, molecular weight is 216.19.
Substrate among the present invention includes but not limited to polyethylene glycol 6000, Macrogol 4000, polyethylene glycol 1500, cetomacrogol 1000, sodium stearate, glycerin gelatine, poloxamer, stearic acid, glycerol monostearate acid, insect wax etc.
Coolant among the present invention includes but not limited to dimethicone, liquid paraffin, vegetable oil, water, alcoholic solution etc.
Below through detecting to beneficial effect of the present invention as directed
One, detects index and method
1. disintegrate (molten loosing) time limit: check according to inspection technique disintegration (two appendix XA of Chinese Pharmacopoeia version in 2000).
2. dissolution rate: sample thief, according to dissolution method (two appendix XC second methods of Chinese Pharmacopoeia version in 2000), with 0.25% sodium dodecyl sulfate solution 900ml is solvent, rotating speed is that per minute 150 changes, operation in accordance with the law, through 10,20,30, in the time of 40 minutes, get solution 10ml, filter, precision is measured subsequent filtrate 5ml and is put in the 10ml measuring bottle, add filtered in advance 0.25% sodium dodecyl sulfate solution and be diluted to scale, shake up (unclear, can go again filtration), according to spectrophotography (two appendix IVA of Chinese Pharmacopoeia version in 2000) as solution, with filterable 0.25% sodium dodecyl sulfate solution is blank, measures trap at the wavelength place of 248nm; Precision takes by weighing the methoxsalen reference substance 12.5mg that is dried to constant weight through 105 ℃ in addition, put in the 50ml measuring bottle, add dissolve with ethanol and be diluted to scale, shake up, precision is measured 2ml, puts in the 100ml measuring bottle, add filterable 0.25% sodium dodecyl sulfate solution and be diluted to scale, shake up, measure, calculate stripping quantity with method.
Two, commercially available methoxsalen sheet testing result
1. disintegration time: 65 minutes
2. dissolution rate:
Time (minute) 10 20 30 40
Dissolution (%) 32.4 51.2 71.3 83.5
Three, example 1 sample detection result
1. the molten diffusing time: 3 minutes
2. dissolution rate:
Time (minute) 10 20 30 40
Dissolution (%) 64.7 93.5 98.6 99.7
Four, example 2 sample detection results
1. the molten diffusing time: 3 minutes
2. dissolution rate:
Time (minute) 10 20 30 40
Dissolution (%) 67.4 95.3 97.2 96.4
Five, example 3 sample detection results
1. the molten diffusing time: 3 minutes
2. dissolution rate:
Time (minute) 10 20 30 40
Dissolution (%) 59.8 91.2 99.5 99.8
Six, example 4 sample detection results
1. the molten diffusing time: 3 minutes
2. dissolution rate:
Time (minute) 10 20 30 40
Dissolution (%) 64.2 97.3 99.5 99.6
Seven, example 5 sample detection results
1. the molten diffusing time: 5 minutes
2. dissolution rate:
Time (minute) 10 20 30 40
Dissolution (%) 53.1 92.4 99.0 98.7
Eight, example 6 sample detection results
1. the molten diffusing time: 8 minutes
2. dissolution rate
Time (minute) 10 20 30 40
Dissolution (%) 54.0 92.3 98.5 98.0
The specific embodiment
One, example 1
Prescription:
Methoxsalen 5g
Polyethylene glycol 6000 15g
Make 1000
Method for making: the methoxsalen fine powder that the micronizing of learning from else's experience is crossed 200 mesh sieves is added in the fused polyethylene glycol 6000 substrate, stirs evenly, and with the dimethicone coolant, the dropping preparation method pill, drying, promptly.
Two, example 2
Prescription:
Methoxsalen 5g
Macrogol 4000 15g
Make 1000
Method for making: the methoxsalen fine powder that the micronizing of learning from else's experience is crossed 200 mesh sieves is added in the fused Macrogol 4000 substrate, stirs evenly, and with the dimethicone coolant, the dropping preparation method pill, drying, promptly.
Three, example 3
Prescription:
Methoxsalen 5g
Polyethylene glycol 6000 5g
Macrogol 4000 10g
Make 1000
Method for making: the methoxsalen fine powder that the micronizing of learning from else's experience is crossed 200 mesh sieves is added in fused Macrogol 4000 and the polyethylene glycol 6000 mixed-matrix, stirs evenly, and with the dimethicone coolant, the dropping preparation method pill, drying, promptly.
Four, example 4
Prescription:
Methoxsalen 5g
Glyceryl monostearate 15g
Make 1000
Method for making: the methoxsalen fine powder that the micronizing of learning from else's experience is crossed 200 mesh sieves is added in the fused glyceryl monostearate substrate, and mixing is a coolant with the frozen water, the dropping preparation method pill, and drying, promptly.
Five, example 5
Prescription:
Methoxsalen 5g
Polyethylene glycol 6000 10g
Poloxamer 5g
Make 1000
Method for making: the methoxsalen fine powder that the micronizing of learning from else's experience is crossed 200 mesh sieves is added in fused polyethylene glycol 6000 and the poloxamer mixed-matrix, stirs evenly, and with the dimethicone coolant, the dropping preparation method pill, drying, promptly.
Six, example 6
Prescription:
Methoxsalen 5g
Glyceryl monostearate 15g
Poloxamer 1g
Make 1000
Method for making: get the mixing fine powders that methoxsalen and poloxamer cross 200 mesh sieves through micronizing and be added in the fused glyceryl monostearate substrate, mixing is a coolant with the frozen water, the dropping preparation method pill, and drying, promptly.

Claims (4)

1. methoxsalen drop pill and preparation method thereof is characterized in that: the methoxsalen fine powder of 1 weight portion through micronizing is added in 1~10 weight portion molten matrix, and abundant mixing, dropping preparation method is condensed into ball in coolant, remove coolant, drying, promptly.
2. the chemical name of the described methoxsalen of claim 1 is 9-methoxyl group-7-hydrogen-furan a pair of horses going side by side (3.2-g) (1) benzene a pair of horses going side by side pyrans-7-ketone, and structural formula is , molecular formula is C 12H 8O 4, molecular weight is 216.19.
3. the described substrate of claim 1 includes but not limited to polyethylene glycol 6000, Macrogol 4000, polyethylene glycol 1500, cetomacrogol 1000, sodium stearate, glycerin gelatine, poloxamer, stearic acid, glycerol monostearate acid, insect wax etc.
4. the described coolant of claim 1 includes but not limited to dimethicone, liquid paraffin, vegetable oil, water, alcoholic solution etc.
CNA200410055335XA 2004-08-23 2004-08-23 Dripping pills of methoxsalen and its preparation method Pending CN1602859A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CNA200410055335XA CN1602859A (en) 2004-08-23 2004-08-23 Dripping pills of methoxsalen and its preparation method

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CNA200410055335XA CN1602859A (en) 2004-08-23 2004-08-23 Dripping pills of methoxsalen and its preparation method

Publications (1)

Publication Number Publication Date
CN1602859A true CN1602859A (en) 2005-04-06

Family

ID=34666167

Family Applications (1)

Application Number Title Priority Date Filing Date
CNA200410055335XA Pending CN1602859A (en) 2004-08-23 2004-08-23 Dripping pills of methoxsalen and its preparation method

Country Status (1)

Country Link
CN (1) CN1602859A (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN115414354A (en) * 2022-08-29 2022-12-02 西南医科大学 Application of xanthotoxin in preparation of medicine for treating thrombocytopenia

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN115414354A (en) * 2022-08-29 2022-12-02 西南医科大学 Application of xanthotoxin in preparation of medicine for treating thrombocytopenia

Similar Documents

Publication Publication Date Title
CN1602859A (en) Dripping pills of methoxsalen and its preparation method
CN1562001A (en) Carbazochrome sodium sulfoate dripping pill and its preparing method
CN1528321A (en) Rhizoma gastrodiae extract drop pill and preparing method thereof
CN1602868A (en) Dripping pills of ketotifen fumarate and its preparation method
CN1546022A (en) Dripping pills of luteanine hydrochloride and its preparation
CN1528287A (en) Herba lysionoti extract drop pill and preparing method thereof
CN1528298A (en) Isocarboxazid drop pill and preparing method thereof
CN1582908A (en) Tramadol hydrochloride drops and their preparation
CN1602845A (en) Fenfluramine hydrochloride drop pills and its preparation method
CN1602848A (en) Ambroxol hydrochloride drop pills and its preparation method
CN1602860A (en) Dripping pills of clemastine fumarate and its preparation method
CN1582937A (en) Amiloride hydrochloride drops and their preparation
CN1528301A (en) Nicorandic drop pill and preparing method thereof
CN1528294A (en) Indolol drop pill and preparing method thereof
CN1526394A (en) Buspirone hydrochloride guttate pills and the prepn
CN1526393A (en) Hydralazine hydrochloride guttate pills and the prepn
CN1493290A (en) Ferulaic acid piperazine drip pill and its preparation method
CN1602870A (en) Dripping pills of bucinnazine hydrochloride and its preparation
CN1528286A (en) Soybean aglycone drop pill and preparing method thereof
CN1526382A (en) Sertraline hydrochloride dripping pills and the prepn
CN1493276A (en) Ferulaic acid sodium drip pill and its preparation method
CN1568987A (en) Dripping pills of paroxetine hydrochloride and its preparation method
CN1543961A (en) Oxazepam dripping pills and preparation thereof
CN1562026A (en) Cyclizine hydrochloride dripping pill and its preparing method
CN1526392A (en) Cetirizine hydrochloride guttate pills and the prepn

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C02 Deemed withdrawal of patent application after publication (patent law 2001)
WD01 Invention patent application deemed withdrawn after publication